NASHVILLE, TN / ACCESSWIRE / November 25, 2020 / Right now, in Nashville, Tennessee, one man is revolutionizing the city's nightlife scene and is on track to change the way fast money operates in cities nationwide. Rob Alverson is the founder of Mad Money ATMs, a company that provides Nashville businesses with ATMs at no charge to them. With the hope of expansion soon, Alverson is not only working to grow his own business but is also providing opportunities for growth to businesses all throughout the city of Nashville.

With Mad Money ATMs, businesses in Nashville are able to provide the option of an ATM to their customers without spending a dime. The process of these ATMs is set up so that people who use the ATM will also pay a small surcharge that goes to Mad Money ATMs. Alverson explained the company's process with the following example: "It's essentially recycling cash. Someone withdraws $20 from a machine and that $20 along with the surcharge fee gets sent to [Mad Money]," explains Alverson. The profits received by Alverson's company, then, is what is used to maintain already existing machines and keep up with the increased demand for new businesses.

Not only does Alverson enjoy the success he has been seeing with this company, but he also enjoys the value he can provide to other businesses. "Having an ATM in a business can allow them to go cash only or simply increase their foot traffic by having a machine," shared Alverson. "Also, I love the idea of passive income, essentially having our machines do the work for us." Operating in areas that see a high volume of people, Alverson's machines are usually found in bars and restaurants throughout Nashville's nightlife, but they are also found at gas stations, barbershops, and other small businesses.

Rob Alverson grew up in the city of Nashville and has had an affection for the city since he moved from Detroit as a child. With a knack for entrepreneurship, Alverson has pursued many different entrepreneurial ventures in his life to this point and, through trial and error, found success with Mad Money ATMs at age 25. "Be patient and consistent and understand it doesn't happen overnight. Step outside your comfort zone." These were the tips Alverson shared for how he stayed determined and dedicated to his career goals, but also what he recommends other aspiring entrepreneurs do.

Currently in the middle of the company's most successful year-to-date – during a global pandemic nonetheless – Alverson is expecting even better revenue in 2021 along with potential expansion outside of Nashville. Three years into his venture with Mad Money ATMs, Alverson has overcome rejection and his own self-doubt and replaced the negative energies in his life with a strong support system and a clear vision. Now, the young entrepreneur is poised to revolutionize small business nightlife nationwide.

Learn more about Mad Money ATMs here, and follow the brain behind the company, Rob Alverson, on Instagram.

CONTACT:
Email: info@lostboyentco.com

SOURCE: Lost Boy Entertainment

ReleaseID: 618253

ARCOLOGY NETWORK ACHIEVES MAJOR TECHNICAL MILESTONES TOWARD POTENTIAL COIN OFFERING

VANCOUVER, BC / ACCESSWIRE / November 25, 2020 / Codebase Ventures Inc. ("Codebase" or the "Company") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company's holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, is exploring a potential coin offering, following the results of its first Testnet where the Arcology team achieved major product development milestones.

A coin offering is a natural step to add to the Arcology roadmap based on the success of the first Arcology Testnet. Noting that scalability is single biggest obstacle of blockchain based systems, Arcology demonstrated significant capabilities on this front including:

Highly scalable: With a cluster of commodity computers Arcology has achieved very high results with 33,602 transactions per second (TPS) running complex smart contracts. (The TPS varies depends on number of machines used, the more the faster, which is a unique feature for Arcology. Preliminary results show TPS of 33,602 on a cluster of 12 machines running complex smart contracts, not simple money transfer)

Arcology withstood a very high workload for a prolonged period of time. Arcology has good stability.

The Smart contracts used in the test were written in native Solidity, which is the Ethereum programming language for developer applications on Ethereum network. Arcology has shown excellent compatibility with Ethereum.

"Arcology is designed as a platform for both public and private blockchains," says Arcology Founder and CEO, Mr. Laurent Zhang. Arcology's landscape consists of two independent and standalone platforms named Arcology Network (public) and Arcology Enterprise (private), which based on the same technology core. Arcology Network is a permission-less platform like Bitcoin or Ethereum, while Arcology Enterprise is targeting enterprise users requiring specific privacy features."

Arcology's coins are the native currency of the Arcology network, which mediate all the transactions happening on the platform. The Arcology coins serve some key roles for the network to work properly, including:

Users pay transaction fees for using the platform when the Mainnet is live.

Application developers would deploy their dAPPs on Arcology and earn a profit

Arcology coins would enable the holders to participate in the platform governance

The coin holders are entitled to take a certain percentage out of transaction fees

"As the Arcology team continues to push steadily on the technical side, we are investigating all aspects of a coin offering as a major step in our future," said Mr. Zhang. "Currently, on our roadmap, we are anticipating that the first coin offering would take place prior to the Mainnet going live in the coming months. We are investigating the most favourable approach, and considering all regulatory requirements toward an offering of between 5% – 10% of planned coins to eligible investors in the first coin offering."

For more information on Arcology, please visit the website at https://arcology.network/

About Codebase Ventures Inc.

Codebase Ventures Inc. invests early in great ideas in sectors that have significant upside. We seek the innovators who are establishing tomorrow's standards. We invest early, support those innovators, help take their ideas to market, and work tirelessly to help them realize their vision.

For further information, please contact:

George Tsafalas – Ivy Lu
Investor Relations
Telephone: Toll-Free (877) 806-CODE (2633) or 1 (778) 806-5150
E-mail: IR@codebase.ventures

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

SOURCE: Codebase Ventures Inc.

ReleaseID: 618263

PERTH, AUSTRALIA / ACCESSWIRE / November 25, 2020 / Centamin will host a webcast capital markets event on Wednesday, 2 December 2020. The Company's Chairman and Executive team will provide a presentation outlining the strategic priorities, three-year outlook and opportunities within the Group.

The event will start at 09.00 GMT and, including a Q&A session, is expected to end no later than 11.00 GMT.

EVENT ACCESS

To join the webcast: https://webcasting.buchanan.uk.com/broadcast/5fb2877abe1fd642a3ef21b0. Please allow a few minutes to register.

A recording of the event and presentation material will be available on the Company's website.

QUESTIONS

Investors are welcome to submit questions prior to the event through the above link or by emailing investors@centamin.je.

FOR MORE INFORMATION please visit the website www.centamin.com or contact:

Centamin plc
Alexandra Carse, Investor Relations
+44 (0) 7700 713 738
investors@centamin.je

Buchanan
Bobby Morse / Kelsey Traynor
+ 44 (0) 20 7466 5000
centamin@buchanan.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Centamin PLC

ReleaseID: 618337

Reports increased business activity led by APAC region and automotive sector
No paradigm shift expected on long-term strategy and growth drivers; however near-term outlook impacted by uncertainty from Covid-19

THALWIL, SWITZERLAND / ACCESSWIRE / November 25, 2020 / u-blox (SIX:UBXN)(OTCPINK:UBLXF), a global leader in wireless and positioning technologies, today is hosting its annual Capital Markets' Day for analysts and investors. As part of its business update, u-blox reports that it is observing increased activity across the company's segments and industries following the downturn experienced during the second and third quarters of 2020 due to the difficult Covid-19 environment. u-blox' business activities have rebounded most strongly in APAC where economies reopened earlier compared to other regions. The company also reports that the automotive sector, which was severely impacted by global production and business shutdowns, has exhibited resurgent activity and is a key driver leading the recent rebound of the company's performance. Monthly bookings of purchase orders have increased strongly each sequential month since May.

While recent developments are positive, there is still considerable uncertainty heading into 2021 given the mounting risks from the second wave of Covid-19 infections and ensuing lockdown situations worldwide. The company is focused on ensuring that it remains in a strong financial position and has instituted cost saving and efficiency measures totaling CHF 15 million annualized. R&D priorities and expenditures are being scrutinized in order to balance u-blox's technology leadership and innovation with free cash flow objectives.

Despite the present challenges posed by Covid-19, the company sees no paradigm shifts on the key megatrends driving the long-term strategy and growth perspectives and continues to focus on creating the next generation of wireless connectivity technology.

On the product side, in early November u-blox launched u-blox M10, its latest highly integrated GNSS (global navigation satellite system) platform which was fully designed in-house. With M10, u-blox sets a new benchmark in ultra-low power high performance positioning applications. The M10 is tailored to the needs of wearable and industrial applications, providing ultra-low power positioning performance without sacrificing accuracy and availability. It is ideal for a wide range of small battery-powered applications, including consumer sports watches and asset trackers for varied items such as shipping containers or livestock management. The enhanced capability of u-blox M10 is expected to fuel numerous innovative applications.

Outlook – Full Year 2020
u-blox previously withdrew its full-year 2020 guidance at its half-year 2020 reporting date due to lack of visibility. At this time, due to UK Takeover Code rules and the recent announcement of a possible offer for Telit Communications plc, we are currently unable to provide guidance for full year 2020. The company expects to be able to provide earnings guidance in the near future and will provide an update in due course.

Today's Capital Markets' Day Webcast will take place at 16.00 CET
u-blox is hosting today its Capital Markets' Day event for analysts and investors. Management will conduct a series of formal presentations, followed by a question and answer session. The slide presentation and webcast will be accessible via the Investors section of the company's website at https://www.u-blox.com/en/reporting-center#tab-presentations

Webcast details
Pre-registration link: https://ccwebcast.eu/links/ublox201125/indexl.html

Conference Call
Participants may call the following numbers, 10-15 minutes before the conference call:

Switzerland / Europe: +41 (0) 58 310 50 00
United Kingdom: +44 (0) 207 107 06 13
United States: +1 (1) 631 570 56 13

About u-blox
u-blox (SIX:UBXN) is a global technology leader in positioning and wireless communication in automotive, industrial, and consumer markets. Their smart and reliable solutions, services and products let people, vehicles, and machines determine their precise position and communicate wirelessly over cellular and short range networks. With a broad portfolio of chips, modules, and secure data services and connectivity, u-blox is uniquely positioned to empower its customers to develop innovative and reliable solutions for the Internet of Things, quickly and cost-effectively. With headquarters in Thalwil, Switzerland, the company is globally present with offices in Europe, Asia, and the USA. (www.u-blox.com)
Find us on Facebook, LinkedIn, Twitter @ublox and YouTube

u‑blox investor releations contacts:

Switzerland and Europe:
Doris Rudischhauser, c/o Dynamics Group AG
Phone: +41 79 410 81 88
E-mail: dru@dynamicsgroup.ch

US:
Jeehae Linford, c/o The Equity Group Inc.
Phone: +1 (404) 840-3122
E-mail: jlinford@equityny.com

u‑blox AG
Zürcherstrasse 68
8800 Thalwil
Switzerland
Phone +41 44 722 74 44
Fax +41 44 722 74 47
info@u-blox.com
www.u‑blox.com

Disclaimer
This release contains certain forward-looking statements. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the u-blox Group to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group's products, the potential for the Group's products to become obsolete, the Group's ability to defend its intellectual property, the Group's ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group's ability to generate revenues and profitability, and the Group's ability to realize its expansion projects in a timely manner. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this report. u-blox is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise.

This press release is published in German and English. Should the German translation differ from the English original, the English version is binding.

SOURCE: u-blox AG via EQS Newswire

ReleaseID: 618334

Amended US Licensing Agreement Allows for US Expansion

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / (CSE:OVAT)(OTC PINK:OVATF) – Ovation Science Inc. ("Ovation" or the "Company") announces that by mutual agreement its Licensing Agreement of November 10, 2017 with Lighthouse Strategies, LLC. ("Lighthouse") has been amended in order to facilitate Ovation's prospective expansion plans into additional states beyond Nevada in the US (the "Amendment"). Due to the continuing refinement of Ovation's business strategy for its cannabis products and because of Lighthouse's success in Nevada with Ovation's topical cannabis products, Lighthouse will focus its efforts on expanding its leadership in topicals in Nevada for a period of one year; renewable by mutual consent. In connection with the Amendment, Lighthouse will have the exclusive rights to Ovation's topical products containing THC and sold exclusively in Nevada dispensaries and the non-exclusive rights to Ovation's topical CBD products in Nevada only. Along with the previous terms of the Agreement, the Amendment specifies a Minimum Quarterly payment.

"The cannabis industry has evolved tremendously in the past three years when we first introduced Ovation's formulations into the US marketplace and notably even in the past two weeks following the US election." said Mr. Terry Howlett, President of Ovation. "We are focused on creating greater shareholder value and therefore are excited to now have the opportunity to seek additional licensees across the United States with this new Amendment in place. Our strategic growth plan is to secure multi-state operators through-out the US that have the infrastructure and marketing expertise in their regions to launch Ovation's CBD and THC topical products of which we have over 25 formulations developed including our beauty line ARLO CBD Beauty and our wellness line Invibe®MD. We have already proven the superiority of our products in Nevada with Lighthouse and believe this can be duplicated and expanded into other states." He added, "We also realize that there are Canadian and European companies that are seeking a foot-hold into the US market with science-based cannabis topical products and we will pursue those opportunities as well."

The recent changes to the cannabis market have highlighted greater opportunity for expanded US distribution of Ovation's patented topical and transdermal products. The pandemic has not slowed down overall cannabis sales, in fact, most US states and Canada showing record sales since the spring. (Sources: NewCannabisVentures.com, Sept 2020 "July Cannabis Sales Surge in 5 Western States" and Statista.com: www.statista.com/statistics/1045766/cannabis-store-sales-canada/). The election results showed that the legalization of marijuana continues to be widely accepted as shown by the recent unanimous approval of five more states legalizing medical or recreational marijuana (Arizona, Mississippi, Montana, New Jersey, and South Dakota). Additionally, there are over 90 bills in front of Congress including a comprehensive Democratic initiative called the More Act which could legalize cannabis federally. (TheFreshToast.com, Oct. 22, 2020: "Why The 2020 Election Could Change Everything For The Cannabis Industry".) This new legislation will be decidedly impactful for the cannabis industry with edibles and topicals standing to gain significantly from these changes to federal restrictions (Source: Happi.com 04.10.20 "MarketWatch: CBD Edibles & Topicals Expected to Gain Share of Cannabis Market").

Medical marijuana is now legal in 36 states plus the District of Columbia with 15 states having both medical and recreational cannabis approved. According to Statista.com, by 2024 retail sales of marijuana could reach as high as US$ 12 billion in sales, with medical marijuana sales expected to double. The CBD skin care market, one of markets where Ovation is position, is projected to reach US$959 million by 2024 (Source: Prohibition Partners: "The Impact Series: Disrupting Beauty.")

For information about Ovation Science products visit: https://ovationscience.com/products/.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including DermSafe® hand sanitizer and its two CBD product lines ARLO CBD Beauty and InVibe® MD, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation's management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees along with revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT and in the USA on OTC markets under the symbol OVATF. Visit our website www.ovationscience.com for more information.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance of expansion of its products in the US or elsewhere nor that a change in legislation will occur or have an impact. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.'s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.

Neither the Canadian Securities Exchange, OTC Markets nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

INVESTOR RELATIONS:
Sebastian Kunyz: ovat@kincommunications.com Phone: 604-684-6730 or Toll Free at 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:
Doreen McMorran: doreen@ovationscience.com Phone: 604-283-0903 ext. 4

SOURCE: Ovation Science Inc.

ReleaseID: 618072

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / Chemesis International Inc. (the "Company") (CSE:CSI)(OTCQB:CADMF)(FRA:CWAA)

The Company announces that its (former) subsidiary, Natural Ventures PR, LLC ("NVPR"), has sold all of its cannabis assets, and assigned all related liabilities, licenses and permits, to Puerto Rico Industrial Commercial Holdings Biotech Corp. ("PRICH") in exchange for immediate net cash proceeds to the Company, in respect of its 80% interest in NVRP, of US$450,000. The Company notes that, in connection with, and as a condition to, this transaction, it will cease to be a shareholder of NVPR.

The Company also announces that its subsidiary, GSRX Industries Inc. ("GSRX"), has sold all of its Puerto Rican cannabis assets, and assigned all related liabilities, licenses and permits, to PRICH in exchange for immediate net cash proceeds to GSRX of US$2,250,000, and monthly payments to be received in the amount of US$100,000 over a period of 24 months.

On Behalf of The Board of Directors
Josh Rosenberg
President

Investor Relations:

ir@chemesis.com
1 (604) 398-3378

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Chemesis International Inc.

ReleaseID: 618157

LAS VEGAS, NV / ACCESSWIRE / November 24, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, just announced the limited-edition collaboration between its branded division, City Trees, and State Flower, a renowned cannabis cultivator with distribution and cultivation operations in San Francisco and Las Vegas.

The two sustainability-minded brands make a perfect pair for this collaborative project. With City Trees' commitment to recyclable packaging and environmental stewardship and State Flower's complementary ethos, featuring Environcann certified cultivation practices, the two companies have come together to produce a concentrate that is both mindful of the planet and of the highest quality.

The selected strain, Wedding Cake, was chosen for this collaboration for its longstanding popularity across multiple markets. Further, the robust resin production of this strain creates higher yields during the extraction process, and the distinct strains crossed to produce this cultivar create a full-bodied, unique aroma and terpene profile that is highly desirable in the cannabis industry. This collaboration project represents the first live resin – produced from fresh plant material rather than dried and cured material – interpretation of this highly sought after strain as presented by State Flower.

Through a carefully curated Vendor Qualification process, City Trees and State Flower elected to collaborate in a joint effort to represent the unique expertise presented by both organizations, while embracing their shared focus on sustainability and quality. Combining forces offered an opportunity for both organizations to showcase the best of what they offer in one product. This collaboration represents the first co-branded offering from City Trees as it looks to expand and refine its concentrate division – a category in which City Trees has seen over 115% growth in unit sales year-over-year through September 2020.

While this project is the first fully co-branded concentrate released from the City Trees laboratory, the brand has now produced extraction products in coordination with multiple renowned cultivators in the Nevada cannabis market through its toll processing services. CLS, through its City Trees division, continues to forge strong partnerships with its peers in pursuit of its mission to produce the highest quality, cleanest extraction products available in the cannabis industry.

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/.Twitter: @CLSHoldingsUSA

About City Trees

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com

Forward Looking Statements

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, the potency and desirability of certain of our offered strains, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

Contact Information:

Corporate:

Chairman and CEO
Jeff Binder

President and COO
Andrew Glashow

888-438-9132

Investor Relations:
investors@clsholdingsinc.com

SOURCE: CLS Holdings USA, Inc.

ReleaseID: 618238

Q3 2020 Revenue of $22.8 million; Adjusted EBITDA of $6.2 million

All figures are reported in United States dollars ($) unless otherwise indicated

LAS VEGAS, NV / ACCESSWIRE / November 24, 2020 / Planet 13 Holdings Inc. (CSE:PLTH) (OTCQB:PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company, today announced its financial results for the three-month and nine-month period ended September 30, 2020. Planet 13's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

Larry Scheffler, Co-CEO of Planet 13 said, "Our performance in the third quarter exceeded expectations – leading to our highest quarter of sales ever. Despite being impacted by the ongoing global pandemic and our Las Vegas SuperStore only at 50% capacity, we achieved 36% higher revenue compared to pre-COVID quarters. This is a testament to the strength of Planet 13's business model and the success of the operational improvements we put in place to ensure our ability to serve local customers. As Las Vegas returns to normal and the economy recovers, we will undertake further strategic initiatives to grow revenue at the SuperStore and increase our sales to local customers in Las Vegas."

"In the third quarter, our in-house brands contributed 25% to SuperStore revenue – continuing to be one of the most recognized and fastest-growing segments within the Planet 13 portfolio. In the wholesale market we saw increasing sales month over month throughout the quarter and continuing into October. Building on this momentum, we continue to invest in cultivation with our recently announced acquisition of a 45,000 square foot facility in Las Vegas, better positioning us to supply wholesale and retail sales within the state," commented Bob Groesbeck, Co-CEO. "We are excited to leverage our knowledge and experience from Nevada to California, with the opening of our new dispensary in Santa Ana in 2021 – the world's second largest dispensary. Planet 13 is well capitalized, and we look forward to executing on future expansion into other major growth markets."

Financial Highlights – Q3 – 2020

Operating Results

All comparisons below are to the quarter ended September 30, 2019, unless otherwise noted

Revenues were $22.8 million as compared to $16.7 million, an increase of 36.5%
Gross profit before biological adjustments was $13.0 million or 56.9% as compared to $9.9 million or 59.1%, an increase of 31.4%
Operating expenses, excluding non-cash compensation expense and depreciation and amortization, was $7.2 million as compared to $6.7 million, an increase of 7.9%
Net income before taxes of $3.4 million as compared to a net income of $0.3 million
Net income of $0.2 million as compared to a net loss of $1.7 million
Adjusted EBITDA of $6.2 million as compared to Adjusted EBITDA of $3.4 million

Balance Sheet

All comparisons below are to December 31, 2019, unless otherwise noted

Cash of $56.8 million as compared to $12.8 million
Total assets of $125.5 million as compared to $62.9 million
Total liabilities of $39.3 million as compared to $21.6 million

Q3 Highlights and Recent Developments

For a more comprehensive overview of these highlights and recent developments, please refer to Planet 13's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three Months and Nine Months Ended September 30, 2020 (the "MD&A").

On July 3, 2020, Planet 13 announced closing of a CDN$11.5 million bought deal public offering.
On July 17, 2020, Planet 13 announced an acquisition of 45,000 square feet of indoor cultivation.
On August 10, 2020, Planet 13 was awarded a Nevada dispensary license.
On August 20, 2020, Planet 13 announced a CDN$15 million bought deal public offering.
On August 21, 2020, Planet 13 announced an upsize to bought deal public offering to CDN$20 million.
On September 10, 2020, Planet 13 announced closing of a CDN$23 million bought deal public offering.
On October 13, 2020, Planet 13 announced the addition of non-cannabis retail space to the Las Vegas SuperStore.
On October 19, 2020, Planet 13 announced expanding the dispensary floor of the Las Vegas SuperStore.
On October 19, 2020, Planet 13 announced a CDN$20 million bought deal public offering.
On October 20, 2020, Planet 13 announced an upsize to bought deal public offering to CDN$25 million.
On November 5, 2020, Planet 13 announced the closing of a CDN$28.8 million bought deal public offering.
On November 20, 2020, Planet 13 announced opening the Medizin dispensary.

Results of Operations (Summary)

The following tables set forth consolidated statements of financial information for the three-month and nine-month periods ending September 30, 2020 and September 30, 2019. For further information regarding the Company's financial results for these periods, please refer to the Company's interim financial statements for the period ended September 30, 2020 together with the MD&A, available on Planet 13's issuer profile on SEDAR at www.sedar.com and the Company's website https://www.planet13holdings.com.

Adjusted EBITDA

 
NV Cannabis Ops
 
 
Consolidated
 
 
Consolidated
 
 
 
 
 
NV Cannabis Ops
 
 
Consolidated
 
 
 
 
 
 
 

 
Three Months
 
 
Three Months
 
 
Three Months
 
 
 
 
 
Nine Months
 
 
Nine Months
 
 
Nine Months
 
 
 
 

 
Ended
 
 
Ended
 
 
Ended
 
 
Percentage
 
 
Ended
 
 
Ended
 
 
Ended
 
 
Percentage
 

 
Sep-30-2020
 
 
Sep-30-2020
 
 
Sep-30-2019
 
 
Change
 
 
Sep-30-2020
 
 
Sep-30-2020
 
 
Sep-30-2019
 
 
Change
 

EBITDA

Profit (loss) before taxes

 
 
4,811,541
 
 
 
3,371,829
 
 
 
251,122
 
 
 
1242.7
%
 
 
5,124,677
 
 
 
389,503
 
 
 
1,457,619
 
 
 
(73.3
%)

Add back:

Biological asset adjustments

 
 
504,069
 
 
 
504,069
 
 
 
52,291
 
 
 
864.0
%
 
 
225,294
 
 
 
225,294
 
 
 
129,101
 
 
 
74.5
%

Non-cash share based payments

 
 
–
 
 
 
569,227
 
 
 
2,016,803
 
 
 
(71.8
%)
 
 
–
 
 
 
2,006,067
 
 
 
3,128,417
 
 
 
(35.9
%)

Depreciation and amortization

 
 
1,076,774
 
 
 
1,076,774
 
 
 
680,056
 
 
 
58.3
%
 
 
3,103,847
 
 
 
3,103,847
 
 
 
1,945,186
 
 
 
59.6
%

Depreciation included in COGS

 
 
406,322
 
 
 
406,322
 
 
 
157,297
 
 
 
158.3
%
 
 
819,579
 
 
 
819,579
 
 
 
286,987
 
 
 
185.6
%

Interest and non-operating expense (income)

 
 
264,542
 
 
 
264,542
 
 
 
211,298
 
 
 
25.2
%
 
 
1,041,745
 
 
 
1,041,745
 
 
 
625,674
 
 
 
66.5
%

EBITDA

 
 
7,063,248
 
 
 
6,192,763
 
 
 
3,368,867
 
 
 
83.8
%
 
 
10,315,142
 
 
 
7,586,035
 
 
 
7,572,984
 
 
 
(0.2
%)

Margin

 
 
31.0
%
 
 
27.2
%
 
 
20.2
%
 
 
 
 
 
 
20.5
%
 
 
15.1
%
 
 
16.1
%
 
 
 
 

Expressed in USD$

 
Three Months
 
 
Three Months
 
 
 
 

 
Ended
 
 
Ended
 
 
Percentage
 

 
Sep-30-2020
 
 
Sep-30-2019
 
 
Change
 

Revenue

Revenues, net of discounts

 
 
22,797,338
 
 
 
16,696,932
 
 
 
36.5
%

Cost of Goods Sold

 
 
(9,821,561
)
 
 
(6,820,706
)
 
 
44.0
%

Gross Profit, Before Biological Asset Adjustment

 
 
12,975,777
 
 
 
9,876,226
 
 
 
31.4
%

Gross Profit Margin %

 
 
56.9
%
 
 
59.1
%
 
 
 
 

Realized fair value amounts included in COGS

 
 
(961,235
)
 
 
(562,461
)
 
 
70.9
%

Unrealized fair value gain on growth of biological assets

 
 
457,166
 
 
 
510,170
 
 
 
(10.4
%)

Gross profit

 
 
12,471,708
 
 
 
9,823,935
 
 
 
27.0
%

Gross Profit Margin %

 
 
54.7
%
 
 
58.8
%
 
 
 
 

Expenses

General and Administrative

 
 
6,198,121
 
 
 
4,902,355
 
 
 
26.4
%

Sales and Marketing

 
 
991,215
 
 
 
1,762,301
 
 
 
(43.8
%)

Depreciation and Amortization

 
 
1,076,774
 
 
 
680,056
 
 
 
58.3
%

Share based payments

 
 
569,227
 
 
 
2,016,803
 
 
 
(71.8
%)

Total Expenses

 
 
8,835,337
 
 
 
9,361,515
 
 
 
(5.6
%)

Income (Loss) From Operations

 
 
3,636,371
 
 
 
462,420
 
 
 
686.4
%

Other (Income) Expense:

Interest Expense, net

 
 
438,687
 
 
 
314,389
 
 
 
39.5
%

Realized Foreign Exchange gain (loss)

 
 
–
 
 
 
(6,203
)
 
 
(100.0
%)

Other expense (income)

 
 
(174,145
)
 
 
(96,888
)
 
 
79.7
%

Total Other Expense (Income)

 
 
264,542
 
 
 
211,298
 
 
 
25.2
%

Income (loss) for the period before tax

 
 
3,371,829
 
 
 
251,122
 
 
 
1242.7
%

Provision for income tax (current and deferred)

 
 
3,010,880
 
 
 
1,973,475
 
 
 
52.6
%

Income (Loss) for the period

 
 
360,949
 
 
 
(1,722,353)
 
 
 
(121.0
%)

Other Comprehensive Income (Loss)

Items that may be reclassified subsequently to profit/loss

Foreign exchange translation adjustment

 
 
(152,313
)
 
 
28,932
 
 
 
 
 

Net Comprehensive Income (Loss) for the period

 
 
208,636
 
 
 
(1,693,421)
 
 
 
 
 

Income (Loss) per share for the period

Basic and fully diluted loss per share

 
$
0.00
 
 
$
(0.01)
 
 
 
 
 

Weighted Average Number of Shares Outstanding

Basic and fully diluted

 
 
162,536,424
 
 
 
135,503,007
 
 
 
 
 

Outstanding Shares

As of November 24, 2020, the Company had 121,987,683 common shares and 55,232,940 class A convertible, restricted voting shares issued and outstanding for a total of 177,220,623 shares outstanding. There were 333,840 options issued and outstanding of which all have fully vested. There were 11,743,904 warrants outstanding and 1,764,250 RSU's outstanding of which nil RSUs had fully vested as at the date of this MD&A.

Conference Call

Planet 13 will host a conference call on Tuesday, November 24, 2020 at 5:00 p.m. EST to discuss its third quarter financial results and provide investors with key business highlights. The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO.

CONFERENCE CALL DETAILS

Date: November 24, 2020 | Time: 5:00 p.m. EST
Participant Dial-in: Toll Free 877-407-8035 or International 201-689-8035
Replay Dial-in: Toll Free 877-481-4010 or International 919-882-2331
(Available for 2 weeks)
Reference Number: 38726
Listen to webcast: https://bit.ly/358WpIA

Financial Measures

There are measures included in this news release that do not have a standardized meaning under generally accepted accounting principles (GAAP) and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is calculated as net earnings before finance costs (net of finance income), income tax expense, and depreciation and amortization of intangibles and is a non-GAAP financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.

For further inquiries, please contact:

LodeRock Advisors Inc., Planet 13 Investor Relations
mark.kuindersma@loderockadvisors.com
(416) 519-2156 ext. 2230

Bob Groesbeck and Larry Scheffler
Co-Chief Executive Officers
ir@planet13lasvegas.com

About Planet 13

Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas – the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, Planet 13's first California location and the timeline for opening of the Santa Ana dispensary.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; risks associated with COVID-19 and other infectious diseases presenting as major health issues; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada and California cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada and California; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through licensed subsidiary entities in states that have legalized marijuana operations, however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business, including COVID-19, are contained under the heading "Risk Factors" and elsewhere in the Company's annual information form dated April 13, 2020 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Expressed in United States Dollars

 
As at
 
 
As at
 

 
September 30,
 
 
December 31,
 

 
2020
 
 
2019
 

Assets

Current Assets

Cash

 
$
56,760,860
 
 
$
12,814,712
 

HST receivable

 
 
63,860
 
 
 
16,544
 

Inventories (Note 5)

 
 
7,721,586
 
 
 
5,474,004
 

Biological assets (Note 6)

 
 
1,370,090
 
 
 
514,526
 

Prepaid expenses and other current assets (Note 10)

 
 
2,153,334
 
 
 
3,694,272
 

Total Current Assets

 
 
68,069,730
 
 
 
22,514,058
 

Property and equipment (Note 7)

 
 
31,638,285
 
 
 
30,211,154
 

Licenses (Note 8)

 
 
6,215,073
 
 
 
–
 

Right of use assets (Note 9)

 
 
18,520,944
 
 
 
9,478,733
 

Long-term deposits and other assets

 
 
1,031,352
 
 
 
694,601
 

 
 
57,405,654
 
 
 
40,384,488
 

Total Assets

 
$
125,475,384
 
 
$
62,898,546
 

Liabilities

Current Liabilities

Accounts payable (Note 16)

 
$
2,095,692
 
 
$
864,260
 

Accrued expenses

 
 
3,026,090
 
 
 
1,910,046
 

Income taxes payable

 
 
12,356,301
 
 
 
7,015,606
 

Notes payable – current portion (Note 11)

 
 
884,000
 
 
 
884,000
 

Total Current Liabilities

 
 
18,362,083
 
 
 
10,673,912
 

Long -term lease liabilities (Note 12)

 
 
20,437,005
 
 
 
10,522,377
 

Other long-term liabilities

 
 
28,000
 
 
 
28,000
 

Deferred tax liability

 
 
467,486
 
 
 
379,665
 

 
 
20,932,491
 
 
 
10,930,042
 

Total Liabilities

 
 
39,294,574
 
 
 
21,603,954
 

Shareholders' Equity

Share capital (Note 13)

 
 
101,809,657
 
 
 
51,986,849
 

Restricted share units (Note 13)

 
 
2,719,357
 
 
 
4,119,485
 

Warrants (Note 13)

 
 
7,753,818
 
 
 
5,961,091
 

Option reserve (Note 13)

 
 
311,401
 
 
 
399,439
 

Accumulated other comprehensive loss

 
 
(812,650
)
 
 
(607,707
)

Deficit

 
 
(25,600,773
)
 
 
(20,564,565
)

Total Shareholders' Equity

 
 
86,180,810
 
 
 
41,294,592
 

Total Liabilities and Shareholders' Equity

 
$
125,475,384
 
 
$
62,898,546
 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND
COMPREHENSIVE INCOME (LOSS)

Expressed in United States Dollars

 
Three months
 
 
Three months
 

 
Ended
 
 
Ended
 

 
September 30,
 
 
September 30,
 

 
2020
 
 
2019
 

Revenue

Revenues, net of discounts

 
$
22,797,338
 
 
$
16,696,932
 

Cost of Goods Sold

 
 
(9,821,561
)
 
 
(6,820,706
)

Gross Profit before fair value asset adjustment

 
 
12,975,777
 
 
 
9,876,226
 

Realized fair value amounts included in inventory sold

 
 
(961,235
)
 
 
(562,461
)

Unrealized fair value gain on growth of biological assets

 
 
457,166
 
 
 
510,170
 

Gross Profit

 
 
12,471,708
 
 
 
9,823,935
 

Expenses

General and Administrative (Note 14)

 
 
6,198,121
 
 
 
4,902,355
 

Sales and Marketing

 
 
991,215
 
 
 
1,762,301
 

Depreciation and Amortization (Note 7 & 9)

 
 
1,076,774
 
 
 
680,056
 

Share-Based Compensation Expense (Note 13 and Note 16)

 
 
569,227
 
 
 
2,016,803
 

Total Expenses

 
 
8,835,337
 
 
 
9,361,515
 

Income (Loss) From Operations

 
 
3,636,371
 
 
 
462,420
 

Other Expense:

Interest expense, net

 
 
438,687
 
 
 
314,389
 

Realized foreign exchange loss

 
 
–
 
 
 
(6,203
)

Other income

 
 
(174,145
)
 
 
(96,888
)

Total Other Expense

 
 
264,542
 
 
 
211,298
 

Income (Loss) before income taxes

 
 
3,371,829
 
 
 
251,122
 

Provision for tax – current

 
 
2,620,603
 
 
 
2,172,429
 

Provision for tax – deferred

 
 
390,277
 
 
 
(198,954
)

Income (Loss) for the Period

 
$
360,949
 
 
$
(1,722,353)
 

Other Comprehensive Income

Foreign exchange translation gain (loss)

 
 
(152,313
)
 
 
28,932
 

Net Comprehensive Income (Loss) for the Period

 
$
208,636
 
 
$
(1,693,421)
 

Income (Loss) per share for the Period

Basic and diluted Income (loss) per share

 
$
0.00
 
 
$
(0.01)
 

Weighted Average Number of Common Shares Outstanding

Basic and Diluted

 
 
162,536,424
 
 
 
135,503,007
 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Expressed in United States Dollars

 
Nine Months
 
 
Nine Months
 

 
Ended
 
 
Ended
 

 
September 30,
 
 
September 30,
 

 
2020
 
 
2019
 

Operating activities

Net loss for the period

 
$
(5,036,208
)
 
$
(4,081,165
)

Add (deduct) non-cash items:

Share based payments (Note 13)

 
 
2,006,067
 
 
 
3,128,417
 

Depreciation and amortization (Note 7 & 9)

 
 
4,451,334
 
 
 
2,417,847
 

Deferred tax liability

 
 
87,821
 
 
 
(198,954
)

Deferred tax asset

 
 
–
 
 
 
–
 

Realized fair value amounts included in inventory sold

 
 
–
 
 
 
(759,856
)

Non-cash interest expense on ROU Liabilities (Note 12)

 
 
1,769,500
 
 
 
–
 

Net change in non-cash working capital

HST receivable

 
 
(47,316
)
 
 
77,473
 

Inventories (Note 5)

 
 
(2,247,582
)
 
 
422,949
 

Biological assets (Note 6)

 
 
(855,564
)
 
 
380,263
 

Prepaid expenses and other assets (Note 10)

 
 
1,540,938
 
 
 
(3,226,185
)

Long term deposits and other assets

 
 
(336,751
)
 
 
(85,000
)

Accounts payable

 
 
1,231,431
 
 
 
2,832,431
 

Accrued expenses

 
 
1,116,045
 
 
 
559,030
 

Income tax payable

 
 
5,340,695
 
 
 
5,737,738
 

Other liabilities

 
 
–
 
 
 
407,593
 

Cash flow provided by operating activities

 
 
9,020,410
 
 
 
7,612,581
 

Investing activities

Purchase of property, plant and equipment (Note 7)

 
 
(3,101,240
)
 
 
(12,682,554
)

Purchase of license (Note 8)

 
 
(1,053,353
)
 
 
–
 

Cash flow used in investing activities

 
 
(4,154,593)
 
 
 
(12,682,554)
 

Financing activities

Issuance of shares on warrant and option exercises (Note 13)

 
 
16,941,543
 
 
 
3,965,736
 

Issuance of shares and warrants on financings

 
 
23,807,651
 
 
 
–
 

Payment on lease liabilities

 
 
(1,463,920
)
 
 
(50,614
)

Cash flow provided by financing activities

 
 
39,285,274
 
 
 
3,915,122
 

Net increase in cash

 
 
44,151,091
 
 
 
(1,154,851)
 

Cash at beginning of the period

 
 
12,814,712
 
 
 
19,364,086
 

Effect of foreign exchange on cash

 
 
(204,943
)
 
 
(106,122
)

Cash at end of the period

 
$
56,760,860
 
 
$
18,103,113
 

SOURCE: Planet 13 Holdings Inc.

ReleaseID: 618215

DORADO, PR / ACCESSWIRE / November 24, 2020 / GSRX Industries Inc. (OTC PINK:GSRX) ("GSRX" or, the "Company"), announces that it's wholly-owned subsidiary Project 1493, LLC has sold all of its Puerto Rican cannabis assets, and assigned all related liabilities, licenses and permits, to Puerto Rico Industrial Commercial Holdings Biotech, Corp. in exchange for total aggregate consideration of US$4,643,333, comprised of immediate net cash proceeds to GSRX of US$2,243,333, and monthly payments to be received in the amount of US$100,000 over a period of 24 months.

The Company notes that the Puerto Rico Department of Health has approved these transactions.

About GSRX Industries Inc.
GSRX Industries Inc. (OTC PINK:GSRX), through its subsidiaries, is in the business of distribution, extraction and light manufacturing, and delivery of cannabis and cannabinoid products. GSRX also owns and operates the e-commerce site GetPureAndNatural.com, which offers a broad range of premium hemp extract products.

Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, anticipated revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:
ir@gsrxindustries.com

SOURCE: GSRX Industries Inc.

ReleaseID: 618281

Best Roofing Company of Conyers & Covington GA, Braswell Construction Group, honored with the 2020 Platinum Preferred ‘Product Excellence' Award for their industry-leading contributions to the roofing category.

CONYERS, GA / ACCESSWIRE / November 24, 2020 / Owens Corning Roofing Platinum Preferred Contractor, Braswell Construction Group (BCG), was once again recently honored with the 2020 Platinum Preferred Product Excellence Award for their industry-leading contributions to the roofing category. This industry recognition reflects BCG's continued focus on bringing a results-oriented, customer-driven methodology to running their business and delivering trustworthy, reliable work with superior customer service for their customers. This award commends BCG's ongoing commitment to education, training, and roofing industry product knowledge. The ‘Product Excellence' recognition awarded to Braswell Construction Group distinguishes them from their competitors by acknowledging their excellence in overall System Selling performance for America's number one most trusted and recognized roofing brand, Owens Corning.

Chris Braswell, founder and owner of BCG states, "we recognize that this award is a significant achievement and momentous triumph for our company. We appreciate this high distinction from Owens Corning and thank our loyal customers who continue to trust us to deliver the high-standard of service homeowners deserve."

For more information please visit https://www.braswellconstructiongroup.com

About Owens Corning™ Roofing Platinum Preferred Contractors

Owens Corning is a household name in the roofing industry and helps homeowners across the country choose the most reputable roofing contractor in their area. The Owens Corning Roofing Platinum Preferred Contractor program is considered one of the industry's most exclusive customer reward and loyalty programs. There are 17,000 contractors that supply Owens Corning roofing products. Of those 17,000, just 11,000 contractors receive the "Preferred Contractor" distinction and only 144 of this group are "Platinum" Preferred Contractors. Braswell Construction Group is proud to be a ‘Platinum Preferred Contractor.' To qualify for this exclusive position, BCG not only met the highest standard requirements, but exceeded them in all areas of their trade. Once named as an Owens Corning Platinum Preferred Contractor, the provider is considered among the best in the industry.

About Braswell Construction Group:

Braswell Construction Group (BCG) has been locally owned and operated since 2002, and prides itself on its high-quality craftsmanship, exceptional customer service, and professional acumen. BCG has a reputation for always completing its roofing and restoration projects on time and on budget.

The company states: "BCG is a full-service roofing company with extensive knowledge in many different roofing systems. With our 5-year craftsmanship warranty you can rest at ease that we have you covered." Chris Braswell summarizes his overall mission by offering the following statement. "We strive to achieve the highest quality and reliable services in order to surpass all expectations. Your home is a lifetime investment and your most precious asset; this is why we value each and every customer's desire to have a qualified professional working on the premises of your home."

Braswell Construction Group has been featured several times in Yahoo Finance, ABC, FOX, NBC, among many others as an industry leader and the top Roofing Contractor and best Shake & Slate Roofing Specialist in the state of Georgia. You can learn more about BCG and their high-standing reputation via this past feature in the Associated Press:

https://apnews.com/press-release/pr-accesswire/dcdb6b62c579f5dc53041323283e6797

Braswell Construction Group operates from four Georgia locations to service homeowners with all their roofing and restoration needs in Covington/Conyers, Atlanta, Stone Mountain, Greensboro/Lake Oconee, and their respective surrounding areas.

For more information please visit https://www.braswellconstructiongroup.com

Braswell Construction Group, Inc. Roofing & Restoration
Contact Info:
Name: Michelle Bird
Email: chris@braswellconstructiongroup.com
Organization: Braswell Construction Group, Inc. Roofing & Restoration
Address: 6105 Emory St NW, Covington, GA 30014, United States
Phone: +1-678-283-2551
Website: http://www.braswellconstructiongroup.com

SOURCE: Braswell Construction Group

ReleaseID: 618312